Mrkr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mrkr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mrkr Today - Breaking & Trending Today

LADENBURG THALM/SH SH Begins Coverage on Marker Therapeutics (NASDAQ:MRKR)

LADENBURG THALM/SH SH began coverage on shares of Marker Therapeutics (NASDAQ:MRKR – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage issued a buy rating and a $11.00 target price on the stock. Marker Therapeutics Price Performance NASDAQ MRKR opened at $4.11 on Tuesday. The business’s fifty day moving average price […] ....

United States , Exchange Commission , Marker Therapeutics Company Profile , International Assets Investment Management , Marker Therapeutics Inc , Marker Therapeutics , Free Report , Assets Investment Management , Get Free Report , Marker Therapeutics Daily , Nasdaq Mrkr , Initiated Coverage , Ladenburg Thalm Sh ,

Marker Therapeutics (NASDAQ:MRKR) Now Covered by LADENBURG THALM/SH SH

Equities researchers at LADENBURG THALM/SH SH began coverage on shares of Marker Therapeutics (NASDAQ:MRKR – Get Free Report) in a research note issued on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $11.00 price target on the stock. LADENBURG THALM/SH SH’s price objective points to a potential upside of 157.01% from the […] ....

United States , Marker Therapeutics Inc , Marker Therapeutics Company Profile , International Assets Investment Management , Marker Therapeutics , Get Free Report , Assets Investment Management , Free Report , Marker Therapeutics Daily , Nasdaq Mrkr , Initiated Coverage , Ladenburg Thalm Sh ,

Marker Therapeutics (NASDAQ:MRKR) Coverage Initiated at LADENBURG THALM/SH SH

Equities researchers at LADENBURG THALM/SH SH assumed coverage on shares of Marker Therapeutics (NASDAQ:MRKR – Get Free Report) in a note issued to investors on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $11.00 price target on the stock. LADENBURG THALM/SH SH’s price objective would indicate a potential upside of 157.01% from […] ....

United States , International Assets Investment Management , Marker Therapeutics Company Profile , Exchange Commission , Marker Therapeutics Inc , Marker Therapeutics , Get Free Report , Assets Investment Management , Free Report , Marker Therapeutics Daily , Nasdaq Mrkr , Initiated Coverage , Ladenburg Thalm Sh ,

Marker Therapeutics (NASDAQ:MRKR) Trading 6.4% Higher

Marker Therapeutics, Inc. (NASDAQ:MRKR – Get Free Report) shot up 6.4% during trading on Wednesday . The company traded as high as $5.00 and last traded at $4.64. 42,448 shares traded hands during mid-day trading, an increase of 65% from the average session volume of 25,788 shares. The stock had previously closed at $4.36. Marker […] ....

United States , Renaissance Technologies , Virtu Financial , Marker Therapeutics Inc , Vanguard Group Inc , Millennium Management , International Assets Investment Management , Marker Therapeutics , Get Free Report , Assets Investment Management , Marker Therapeutics Daily , Nasdaq Mrkr ,

Marker Therapeutics, Inc. (NASDAQ:MRKR) Short Interest Update

Marker Therapeutics, Inc. (NASDAQ:MRKR – Get Free Report) saw a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 169,400 shares, a decline of 18.1% from the November 15th total of 206,900 shares. Approximately 2.7% of the shares of the company are sold short. Based […] ....

United States , Millennium Management , Virtu Financial , Renaissance Technologies , Marker Therapeutics Inc , Matrix Asset Advisors Inc , Marker Therapeutics , Get Free Report , Asset Advisors , Marker Therapeutics Daily , Nasdaq Mrkr ,